HKND:NYE-Humankind Benefit Corporation - Humankind US Stock ETF (USD)

ETF | Others |

Last Closing

USD 30.909

Change

-0.17 (-0.54)%

Market Cap

USD 0.14B

Volume

3.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.06 (+0.30%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.17 (+0.30%)

USD 33.49B
DFAC Dimensional U.S. Core Equity 2..

-0.03 (-0.09%)

USD 28.45B
DTB DTB

+0.04 (+0.21%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-0.69 (-1.20%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 23.71B
SGOV iShares® 0-3 Month Treasury B..

+0.04 (+0.04%)

USD 22.84B
AVUV Avantis® U.S. Small Cap Value..

-0.13 (-0.15%)

USD 11.21B
JAAA Janus Detroit Street Trust - J..

+0.04 (+0.08%)

USD 10.41B
DFUV Dimensional US Marketwide Valu..

-0.01 (-0.03%)

USD 10.31B

ETFs Containing HKND

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.64% 63% D 67% D+
Dividend Return 0.83% 41% F 32% F
Total Return 6.47% 63% D 64% D
Trailing 12 Months  
Capital Gain 10.32% 65% D 66% D+
Dividend Return 0.87% 16% F 11% F
Total Return 11.18% 63% D 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.41% 60% D- 47% F
Dividend Return 2.27% 58% F 40% F
Total Return 0.86% 40% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 6.97% 63% D 84% B
Risk Adjusted Return 32.61% 59% D- 55% F
Market Capitalization 0.14B 68% D+ 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.